|
|
 |
|
 |
 |
Print
|
|
|
CMS Releases Final Outpatient Rule and Payment Rates for Blood and Blood Products
The Centers for Medicare and Medicaid Services (CMS) recently announced its final 2007 payment rates for blood and transfusion, bone marrow and hematopoietic stem cell related services provided in the outpatient setting. The rates, which take effect Jan. 1, 2007, were published in the agency’s hospital outpatient prospective payment system (HOPPS) rule for calendar year 2007.
AABB had submitted comments to CMS regarding this rule, specifically noting concerns regarding Medicare’s proposed payment for leukocyte-reduced red blood cells (RBCs) and other frequently transfused blood products. In the comments, AABB noted that CMS’ proposed 2007 payment for leukocyte-reduced RBCs was only $176. In contrast, the U.S. Department of Health and Human Services (HHS) recently published nationwide data in the 2005 Nationwide Blood Collection and Utilization Survey Report indicating that the average hospital payment for leukocyte-reduced RBCs in 2004 was already $201.07 – 13.6 percent higher than the proposed 2007 payment. AABB recommended that CMS base its outpatient payment rate for this product on the 2004 HHS cost data increased by 10 percent (due to inflationary costs and the introduction of new blood safety measures), or $221.18. However, in the final rule, CMS failed to increase its proposed payments for leukocyte-reduced RBCs or other frequently transfused components.
The following tables list Medicare’s 2007 payment rates for blood components as well as transfusion, bone marrow and hematopoietic progenitor cell (HPC) related procedures.
Payments for Blood Components
HCPCS |
APC |
Product/Service |
2006 Final Payment Rate |
2007 Final Payment Rate |
% Change |
|
P9010 |
0950 |
Blood (whole) for transfusion |
$118.04 |
$131.98 |
11.8% |
|
P9012 |
0952 |
Cryoprecipitate |
$47.15 |
$48.59 |
3.1% |
|
P9016 |
0954 |
RBCs, leukocytes reduced |
$163.33 |
$175.74 |
7.6% |
|
P9017 |
9508 |
Plasma 1 donor frz w/in 8 hr |
$70.47 |
$70.21 |
-0.4% |
|
P9019 |
0957 |
Platelet Concentrate |
$51.55 |
$58.95 |
14.4% |
|
P9020 |
0958 |
Platelet Rich Plasma |
$277.73 |
$209.29 |
-24.6% |
|
P9021 |
0959 |
Red Blood Cells |
$121.61 |
$129.53 |
6.5% |
|
P9022 |
0960 |
Washed Red Blood Cells |
$189.42 |
$211.03 |
11.4% |
|
P9023 |
0949 |
Frozen plasma, pooled, sd |
$76.23 |
$57.45 |
-24.6% |
|
P9031 |
1013 |
Platelets leukocyte reduced |
$98.41 |
$95.08 |
-3.4% |
|
P9032 |
9500 |
Platelets irradiated |
$86.64 |
$129.57 |
49.6% |
|
P9033 |
0968 |
Platelets leukocyte reduced irradiated |
$150.74 |
$125.33 |
-16.9% |
|
P9034 |
9507 |
Platelets, pheresis |
$434.48 |
$452.93 |
4.3% |
|
P9035 |
9501 |
Plaetlet pheres leukoreduced |
$493.66 |
$488.74 |
-1.0% |
|
P9036 |
9502 |
Platelet pheresis irradiated |
$326.22 |
$418.52 |
28.3% |
|
P9037 |
1019 |
Plate pheres leukoreduced irradiated |
$581.64 |
$617.40 |
6.2% |
|
P9038 |
9505 |
RBC irradiated |
$147.63 |
$197.00 |
33.4% |
|
P9039 |
9504 |
RBC deglycerolized |
$343.81 |
$358.31 |
4.2% |
|
P9040 |
0969 |
Red blood cell leukocyte reduced irradiated |
$218.27 |
$217.56 |
-0.3% |
|
P9043 |
0956 |
Plasma Protein Fraction, 5%, 50ml |
$68.02 |
$51.26 |
-24.6% |
|
P9048 |
0966 |
Plasmaprotein fract, 5%, 250ml |
$316.05 |
$238.16 |
-24.6% |
|
P9050 |
9506 |
Granulocytes, pheresis unit |
$995.72 |
$750.36 |
-24.6% |
|
P9051 |
1010 |
Blood, l/r, cmv-neg |
$207.95 |
$156.70 |
-24.7% |
|
P9052 |
1011 |
Platelets, hla-m, l/r |
$610.14 |
$671.72 |
10.1% |
|
P9054 |
1016 |
Blood, l/r, froz/degly/wash |
$262.21 |
$211.05 |
-19.5% |
|
P9055 |
1017 |
Plt, aph/pher,l/r, cmv-neg |
$526.57 |
$396.81 |
-26.4% |
|
P9056 |
1018 |
Blood, l/r, irradiated |
$178.56 |
$144.28 |
-19.2% |
|
P9057 |
1021 |
RBC, frz/deg/wsh, l/r, irradiated |
$345.91 |
$496.21 |
43.5% |
|
P9058 |
1022 |
RBC, l/r, cmv-neg, irradiated |
$267.18 |
$262.18 |
-1.9% |
|
P9059 |
0955 |
Plasma, frozen w/in 8-24 hr |
$74.78 |
$76.77 |
2.7% |
|
P9060 |
9503 |
Fr frz plasma donor retested |
$94.82 |
$74.49 |
-21.4% |
Payments for Blood, Bone Marrow and HPC Related Services
APC |
Service |
CPT/HCPCS |
2006 Final Payment Rate |
2007 Final Payment Rate |
% Change |
0003 |
Bone Marrow Biopsy/Aspiration |
38220, 38221 |
$159.23 |
$147.59 |
-7.3% |
|
0110 |
Transfusion |
36430, 36440, 36450, 36455, 36460, 38999,
G0267 |
$216.73 |
$212.58 |
-1.9% |
|
0111 |
Blood Product Exchange |
36511, 36512 , 36513
36514, 38205, 38206,
38242 |
$718.70 |
$720.00 |
0.2% |
|
0112 |
Apheresis, Photopheresis, and Plasmapheresis |
36515, 36516, 36522 |
$1569.60 |
$1857.75 |
18.4% |
|
0123 |
Bone Marrow Harvesting and Bone Marrow/Stem Cell Transplant |
38230, 38240, 38241
|
$1456.95 |
$1251.38 |
-14.1% |
|
0342 |
Level I Pathology
|
80502, 81099, 84999, 85999, 86849, 87999. 88199, 88299, 88314, 88399, 89240 |
$8.63
|
$ 5.06
|
-41.4%
|
|
0343 |
Level III Pathology
|
85097, 86078, 88112, 88172, 88173, 88182, 88189, 88304, 88305, 88319, 88323, 88331, 88333, 88342, 88346
88347, 88355, 88360, 88385, 89049, 89220 |
$27.10
|
32.03
|
18.2% |
|
0344 |
Level IV Pathology |
88307, 88309, 88325, 88356, 88358, 88361, 88362, 88365, 88367, 88368, 88386 |
$45.13 |
$48.73 |
8.0% |
|
0345 |
Level I Transfusion Laboratory Procedures
|
86850, 86903, 86905,
86906, 86921, 86923, 86927, 86945, 86950, 86960, 86970, 86971, 86976, 86985, 86999 |
$12.91
|
$13.39
|
3.7% |
|
0346 |
Level II Transfusion Laboratory Procedures
|
86860, 86870, 86891, 86904, 86920, 86922, 86965, 86972, 86975, 86977, 86978 |
$19.72
|
$21.42
|
8.6% |
|
0347 |
Level III Transfusion Laboratory Procedures
|
86890, 86930, 86931,
86932 |
$49.05
|
$45.63
|
-6.9% |
|
0433 |
Level II Pathology |
80500, 86077, 86079, 88104, 88106, 88107, 88108, 88125, 88160, 88161, 88162, 88184, 88185, 88187, 88188, 88300, 88302, 88311, 88312, 88313, 88318, 88321, 88329, 88332, 88334, 88384, 89230 |
$14.84 |
$15.72 |
5.9% |
Overall, hospital outpatient departments will receive a 3.4 percent market basket update to Medicare payment rates for outpatient services in 2007. According to the American Hospital Association (AHA), hospitals receive “only 87 cents for every dollar of outpatient care they provide to America’s seniors.”
However, AHA has praised CMS for delaying until 2009 its proposed reduction in payment updates if a facility failed to report data on quality of care. Straying from its earlier proposal, the agency announced that it will implement separate quality measures specifically for the outpatient setting.
|
|
|
|
Last modified on 2/23/2007 8:48:21 AM
|
|
|
 |
|
 |
 |
|
 |
 |
|
 | What's New! |  |
 |
| AABB Weekly Report - March 12, 2010 |
|
| Details |
|  |
 |
| National Hemovigilance Program Launches to Track Adverse Events Associated with Blood Transfusion |
|
| Details |
|  |
 |
| AABB Statement on XMRV Task Force |
|
| Details |
|  |
 |
| Updated Circular of Information for Cellular Therapy Products |
|
| Details |
|  |
 |
| Association Bulletin #10-01 - Association Bulletin Listings |
|
| Details |
|  |
 |
| Current U.S. Blood Supply is Adequate to Handle Demands Resulting from Earthquake in Haiti |
|
| Details |
|  |
 |
| Emerging Infectious Disease Agents |
|
| Details |
|  |
 |
| Study Highlights Implications Of Influenza Pandemics On Blood Supplies |
|
| Details |
|  |
 |
| Cellular Therapies Subsections |
|
| Details |
|  |
 |
| Association Bulletin #09-08 - ISBT 128 Conditional Accreditation Status |
|
| Details |
|  |
 |
| AABB Launches Facebook Fan Page |
|
| Details |
|  |
|
|
|
|
|
|
|
|
|
|
|
|